NYSEAMERICAN : CCEL

Cryo-Cell International, Inc. — Financial statements

Healthcare · Medical Care Facilities · United States

Last price 5.21 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 42.01M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Cryo-Cell International, Inc. (CCEL) reported revenue of 31.13M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year December - November; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue31.13M31.57M31.99M31.34M30.34M28.88M
Cost of Revenue11.04M11.74M7.95M12.13M8.79M10.15M
Gross Profit20.09M19.83M24.04M19.22M21.54M18.73M
Selling, General & Admin18.86M18.22M18.52M17.17M15.58M14.61M
Research & Development303.95K376.26K1.24M1.17M384.79K49.87K
Operating Expenses19.90M19.35M20.25M19.46M17.08M15.49M
Operating Income189.42K482.39K3.79M-246.95K4.46M3.24M
Interest Expense-1.82M-2.07M-1.86M-1.24M-1.08M-1.38M
Interest & Investment Income105.89K122.11K
Other Non Operating Income (Expenses)27.36K52.98K6.58K3.44K1.68K99.00
EBT Excluding Unusual Items-1.61M-1.53M2.04M-1.36M3.39M1.86M
Gain (Loss) on Sale of Investments-300.33K-806.27K768.05K50.78K-38.97K-13.06K
Gain (Loss) on Sale of Assets407.34K-15.11K
Asset Writedown-13.11M
Other Unusual Items1.05M-435.33K782.48K
Pretax Income-1.91M-2.34M2.80M-13.36M3.32M2.61M
Income Tax Expense36.82K92.23K2.40M-3.84M547.54K527.71K
Net Income-1.95M-2.43M402.10K-9.52M2.77M2.08M
Net Income to Common-1.95M-2.43M402.10K-9.52M2.77M2.08M
Shares Outstanding (Basic)8.06M8.07M8.13M8.34M8.47M8.14M
Shares Outstanding (Diluted)8.06M8.07M8.21M8.34M8.48M8.36M
EPS (Basic)-0.24-0.300.05-1.140.330.26
EPS (Diluted)-0.24-0.300.05-1.140.330.25
Free Cash Flow4.65M5.25M3.61M2.08M-3.60M6.09M
Free Cash Flow Per Share0.580.650.440.25-0.420.73
Dividend Per Share0.400.25
Gross Margin64.53%62.82%75.15%61.31%71.02%64.85%
Operating Margin0.61%1.53%11.84%-0.79%14.70%11.20%
Profit Margin-6.25%-7.70%1.26%-30.38%9.13%7.21%
Free Cash Flow Margin14.94%16.63%11.28%6.64%-11.85%21.09%
EBITDA1.16M1.47M4.48M1.15M5.96M4.27M
EBITDA Margin3.73%4.65%14.01%3.68%19.64%14.80%
D&A For EBITDA971.38K985.24K693.85K1.40M1.50M1.04M
EBIT189.42K482.39K3.79M-246.95K4.46M3.24M
EBIT Margin0.61%1.53%11.84%-0.79%14.70%11.20%
Effective Tax Rate85.66%16.50%20.21%
Revenue as Reported31.13M31.57M31.99M31.34M30.34M28.88M
Advertising Expenses1.09M1.07M952.59K755.92K841.51K

Balance sheet

Fiscal year December - November; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents1.43M319.03K560.96K406.07K1.70M8.26M
Short-Term Investments2.80M2.98M2.94M574.18K17.62K75.41K
Trading Asset Securities122.11K
Cash & Short-Term Investments4.23M3.30M3.50M1.10M1.72M8.34M
Receivables6.83M6.85M7.31M6.58M6.04M5.25M
Inventory533.56K408.79K657.70K768.88K851.23K921.21K
Prepaid Expenses490.99K573.22K637.05K615.41K566.56K558.41K
Other Current Assets1.08M633.99K454.60K389.95K426.88K711.21K
Total Current Assets13.17M11.76M12.55M9.45M9.61M15.78M
Property, Plant & Equipment21.07M21.85M22.70M22.03M14.21M4.15M
Long-Term Investments308.00K308.00K308.00K
Goodwill1.94M1.94M1.94M1.94M1.94M1.94M
Other Intangible Assets829.61K863.07K921.25K989.12K15.15M16.21M
Long-Term Deferred Tax Assets23.62M23.62M20.80M20.49M13.74M12.01M
Other Long-Term Assets1.67M1.69M5.76M6.01M9.92M10.26M
Total Assets62.30M61.73M64.68M61.22M64.89M60.66M
Accounts Payable2.42M2.87M1.88M3.17M1.61M1.49M
Accrued Expenses2.57M4.28M4.39M3.74M3.24M3.06M
Short-Term Debt2.30M3.52M1.22M2.27M
Current Portion of Long-Term Debt199.18K183.65K170.49K165.64K150.53K1.90M
Current Portion of Leases426.86K430.22K428.33K225.69K297.69K312.07K
Current Income Taxes Payable1.42M1.43M342.11K
Current Unearned Revenue9.72M9.73M9.79M9.70M9.59M9.36M
Other Current Liabilities1.20M1.98M4.96M
Total Current Liabilities15.33M19.79M21.60M20.86M19.48M21.07M
Long-Term Debt8.04M8.17M8.31M8.43M8.58M
Long-Term Leases150.34K474.63K505.05K851.94K313.30K610.99K
Long-Term Unearned Revenue54.25M50.97M46.56M41.19M36.00M31.27M
Other Long-Term Liabilities922.02K922.02K922.02K919.23K2.04M3.52M
Total Liabilities78.70M80.33M77.89M72.25M66.41M56.48M
Common Stock148.85K148.77K148.70K148.49K148.48K146.66K
Additional Paid-In Capital45.05M44.71M44.27M43.41M42.60M41.59M
Retained Earnings-36.57M-38.44M-32.78M-31.16M-21.64M-16.74M
Treasury Stock-25.03M-25.03M-24.86M-23.43M-22.63M-20.81M
Shareholders' Equity-16.39M-18.61M-13.22M-11.03M-1.52M4.18M
Total Liabilities & Equity62.30M61.73M64.68M61.22M64.89M60.66M
Total Debt8.82M11.56M12.93M10.90M11.61M2.82M
Net Cash (Debt)-4.59M-8.26M-9.44M-9.79M-9.89M5.52M
Net Cash Per Share-0.57-1.02-1.15-1.17-1.170.66
Filing Date Shares Outstanding8.06M8.06M8.08M8.29M8.44M8.50M
Total Common Shares Outstanding8.06M8.06M8.08M8.29M8.50M8.56M
Working Capital-2.16M-8.03M-9.04M-11.41M-9.87M-5.29M
Book Value Per Share-2.03-2.31-1.64-1.33-0.180.49
Tangible Book Value-19.17M-21.41M-16.08M-13.96M-18.62M-13.97M
Tangible Book Value Per Share-2.38-2.66-1.99-1.68-2.19-1.63
Buildings19.73M19.73M11.22M11.22M1.51M
Machinery6.03M5.97M8.75M7.74M6.84M
Construction In Progress6.71M
Leasehold Improvements1.23M1.23M1.26M1.26M1.21M

Cash flow statement

Fiscal year December - November; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-1.95M-2.43M402.10K-9.52M2.77M2.08M
Depreciation & Amortization1.35M1.37M1.02M1.71M1.81M1.33M
Other Amortization20.49K20.82K21.24K21.63K15.83K56.85K
Loss (Gain) From Sale of Assets48.30K-407.34K15.11K
Asset Writedown & Restructuring Costs13.11M
Loss (Gain) From Sale of Investments300.33K806.27K-873.94K-172.89K38.97K13.06K
Stock-Based Compensation358.87K417.10K781.13K816.64K461.35K301.62K
Provision & Write-off of Bad Debts1.01M868.79K1.27M1.04M929.62K537.00K
Other Operating Activities1.54M1.54M-309.27K-4.06M-1.30M-1.26M
Change in Accounts Receivable-1.01M-405.88K-2.00M-1.57M-1.72M532.79K
Change in Inventory-72.30K56.19K429.18K360.44K490.00K210.28K
Change in Accounts Payable-191.01K1.00M-423.72K688.93K115.53K532.38K
Change in Unearned Revenue4.39M4.36M5.45M5.30M4.95M4.25M
Change in Other Net Operating Assets-827.54K-2.17M241.25K1.20M411.79K-667.31K
Operating Cash Flow4.92M5.48M6.01M8.92M8.57M7.93M
Capital Expenditures-268.87K-230.47K-2.40M-6.84M-12.17M-1.83M
Sale of Property, Plant & Equipment115.00K1.87M
Sale (Purchase) of Intangibles-1.20M-800.00K-5.00M-5.12M
Investment in Securities-147.39K-859.86K-1.27M-505.79K18.82K
Investing Cash Flow-416.26K-975.33K-4.88M-8.14M-15.28M-6.95M
Short-Term Debt Issued8.80M5.22M950.00K7.67M
Long-Term Debt Issued8.96M
Total Debt Issued3.20M8.80M5.22M950.00K16.63M
Short-Term Debt Repaid-10.02M-2.92M-2.00M-5.40M
Long-Term Debt Repaid-147.57K-136.38K-156.35K-1.95M-4.10M
Total Debt Repaid-6.57M-10.17M-3.06M-2.16M-7.35M-4.10M
Net Debt Issued (Repaid)-3.37M-1.37M2.16M-1.21M9.29M-4.10M
Issuance of Common Stock23.25K23.10K76.40K551.27K1.28M
Repurchase of Common Stock-169.50K-1.42M-799.04K-1.82M-249.38K
Common Dividends Paid-3.23M-2.02M
Other Financing Activities228.00K-67.50K-196.50K
Financing Cash Flow-3.34M-4.75M-979.12K-2.07M147.86K-3.07M
Net Cash Flow1.16M-241.93K154.89K-1.30M-6.56M-2.10M
Free Cash Flow4.65M5.25M3.61M2.08M-3.60M6.09M
Free Cash Flow Margin14.94%16.63%11.28%6.64%-11.85%21.09%
Free Cash Flow Per Share0.580.650.440.25-0.420.73
Levered Free Cash Flow-66.21K580.32K-3.05M-3.99M-15.31M2.38M
Unlevered Free Cash Flow1.05M1.85M-1.91M-3.24M-14.66M3.19M
Cash Interest Paid1.83M2.03M1.98M1.81M1.26M1.04M
Cash Income Tax Paid3.16M4.59M2.72M1.82M1.57M3.53M
Change in Working Capital2.28M2.84M3.70M5.99M4.25M4.86M

Ratios

Fiscal year December - November; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization40.31M34.64M69.90M44.33M37.23M105.60M
Enterprise Value44.90M44.01M79.50M55.55M43.72M101.48M
Last Close Price5.214.308.154.893.999.93
PE Ratio173.8413.4350.68
Forward PE62.5056.0078.82252.0048.56
PS Ratio1.351.102.191.411.233.66
PB Ratio-1.86-5.29-4.02-24.4225.24
P/FCF Ratio9.036.6019.3821.3117.33
P/OCF Ratio8.546.3211.634.974.3413.32
EV/Sales Ratio1.501.392.491.771.443.51
EV/EBITDA Ratio40.1429.9917.7448.197.3423.74
EV/EBIT Ratio245.9991.2420.999.8031.36
EV/FCF Ratio10.028.3922.0426.7016.66
Debt / Equity Ratio-0.54-0.62-0.98-0.99-7.620.67
Debt / EBITDA Ratio5.426.012.637.011.840.61
Debt / FCF Ratio1.902.203.595.240.46
Net Debt / Equity Ratio-0.28-0.44-0.71-0.89-6.49-1.32
Net Debt / EBITDA Ratio3.955.632.118.501.66-1.29
Net Debt / FCF Ratio0.991.572.624.71-2.75-0.91
Asset Turnover0.500.500.510.500.480.54
Inventory Turnover18.5722.0111.1414.979.9210.99
Quick Ratio0.720.510.500.370.400.65
Current Ratio0.860.590.580.450.490.75
Return on Equity (ROE)208.38%274.30%
Return on Assets (ROA)0.19%0.48%3.76%-0.24%4.44%3.79%
Return on Invested Capital (ROIC)0.41%1.14%1.30%-0.58%8.20%
Return on Capital Employed (ROCE)0.40%1.20%8.80%-0.60%9.80%8.20%
Earnings Yield-4.84%-7.01%0.57%-21.48%7.44%1.97%
FCF Yield11.07%15.15%5.16%4.69%-9.66%5.77%
Dividend Yield9.30%2.89%
Payout Ratio502.50%
Buyback Yield / Dilution0.18%1.75%1.54%1.69%-1.46%-2.72%
Total Shareholder Return0.18%11.05%4.43%1.69%-1.46%-2.72%